Arbutus Biopharma Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arbutus Biopharma

ABUS 4.615

+0.5%

Oct 29 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	5/7/2015 2:54:49 PM
	of 42

Tekmira Pharmaceuticals Receives $28.75 Average PT from Analysts (NASDAQ:TKMR) Posted by Rick on May 6th, 2015 Shares of Tekmira Pharmaceuticals (NASDAQ:TKMR) have been given a consensus recommendation of “Buy” by the seven analysts that are currently covering the stock, Analyst Ratings.Net reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $28.75. lulegacy.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next